SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Pacific Biosciences Q3 Revenue Slightly Beats Expectations

Pacific Biosciences' third-quarter revenue slightly exceeded expectations; the headline cites adoption of SPRQ-Nx.

PACB

Related stories